Resolys Bio Overview

  • Founded
  • 2016

Founded
  • Status
  • Private

  • Employees
  • 4

Employees
  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $200K

Resolys Bio General Information

Description

Operator of a clinical-stage biotechnology company intended to develop therapeutic agents for chronic disorders. The company focuses on traumatic brain injury (TBI) and chronic tissue disorders such as joint hypermobility syndromes (JHS), lupus, rheumatoid arthritis, and fibromyalgia, helping clinicians to treat patients with drug development programs.

Contact Information

Website
resolysbio.com
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 545 Westfall Road
  • Delanson, NY 12053
  • United States
+1 (518) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Resolys Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 25-Sep-2017 $200K 00000 Completed Pre-Clinical Trials
To view Resolys Bio’s complete valuation and funding history, request access »

Resolys Bio Patents

Resolys Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018389242-A1 Compositions and methods of treatment of ehlers-danlos syndromes Pending 21-Dec-2017 000000000
US-20200338147-A1 Compositions and methods of treatment of ehlers-danlos syndromes Pending 21-Dec-2017 000000000
CA-3086642-A1 Compositions and methods of treatment of ehlers-danlos syndromes Pending 21-Dec-2017 000000000
EP-3727436-A1 Compositions and methods of treatment of ehlers-danlos syndromes Pending 21-Dec-2017 000000000
JP-2021506980-A Therapeutic compositions and treatments for ehlers-danlos syndrome Pending 21-Dec-2017 A61P19/02
To view Resolys Bio’s complete patent history, request access »

Resolys Bio Executive Team (3)

Name Title Board Seat Contact Info
Thomas Hatch Executive Vice President & Board Member
Richard Sandberg Chief Executive Officer & Co-Chairman
John McMichael Ph.D President & Co-Chairman
To view Resolys Bio’s complete executive team members history, request access »

Resolys Bio Board Members (9)

Name Representing Role Since
Chris Garabedian Resolys Bio Board Member 000 0000
Damian Marron Self Board Member 000 0000
James Tobin Self Board Member 000 0000
Jeffrey Eckmann Resolys Bio Board Member 000 0000
John McMichael Ph.D Self President & Co-Chairman 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Resolys Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial